Joshua Rhein, MD, assistant professor of medicine at the University of Minnesota, discusses whether obesity affects vaccine response and what can be done.
Investigators know that obesity affects how well a patient responds to a vaccine. However, according to Joshua Rhein, assistant professor of medicine at the University of Minnesota in the division of infectious disease in the program of HIV medicine, University of Minnesota Medical Center, why vaccines are not as effective in patients who are obese. Rhein spoke with Infection Control Today® about the subject in a 2-part interview.
Rhein discusses how investigators are researching the connection between obesity and vaccine response. “It’s poorly understood and under research, but we do know that obesity itself can affect the immune system. We know this from different vaccine studies that we've done and epidemiology studies on kinds of infection rates. Overall, we don't understand how this works, and more research is needed to determine the link between obesity and reduction [of infection rates],” according to Rhein.
Part of the reason that obesity is not well understood is “it's something that isn't routinely collected. When we're collecting study data on vaccines is something other than what we usually think of as having an important effect on immune responses. Hopefully, as we recognize that there is a link between obesity, the immune system, and vaccine effectiveness, patient weight is something that we can start to collect routinely,” Rhein told ICT. “Not once either because [a patient’s weight] is such a liquid measure, something that can be measured throughout participation and clinical trials.”
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.